探索免费可用的药物坚持应用程序的输出与用户需求之间的匹配:混合方法研究
Kirstin Messner1, Vanessa Sutter1,2, Samuel Allemann1
1Department Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
JMIR mHealth and uHealth
|December 16, 2025
概括
智能手机遵守应用程序部分满足用户的需求,特别是在与医疗保健专业人员 (HCP) 进行数据解释方面. 应用程序可以增强患者护理,但不能取代医疗保健人员.
科学领域:
- 数字健康数字健康
- 医疗信息学 医疗信息学
- 移动健康 (mHealth) 服务提供商
背景情况:
- 药物不坚持是成功治疗的主要障碍.
- 智能手机应用程序为简单的坚持干预提供了潜力.
- 现有的遵守应用程序在内容,质量和数据输出方面存在很大差异.
研究的目的:
- 为了评估智能手机的坚持应用程序输出与理想的功能.
- 探索用户对坚持应用程序功能的需求.
- 评估应用程序功能与用户需求之间的对齐.
主要方法:
- 搜索了应用程序存储库的坚持应用程序,选80的资格.
- 包括9个免费的应用程序来分析输出功能.
- 开展了重点小组 (n=8) 和在线调查 (n=42) 以确定用户需求.
主要成果:
- 追踪历史记录是最常见的功能 (8/9个应用程序);其他可取的功能不那么频繁.
- 用户希望拥有专业反,摄入建议和HCP讨论选项等功能.
- 追踪历史是最想要的 (平均5.29),而奖励是最不想要的 (平均2.81).
结论:
- 免费可用的执法应用程序输出仅部分与用户需求保持一致.
- 用户优先考虑数据解释和与医疗保健专业人员 (HCP) 的讨论.
- 坚持应用程序可以补充,而不是取代,医疗保健人员在患者护理.
相关概念视频
Measurement of Bioavailability: Pharmacodynamic Methods
212
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
212
Bioavailability Study Design: Healthy Subjects Versus Patients
133
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
133
Drug Therapy
232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
232
Analysis of Population Pharmacokinetic Data
653
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
653
Dosage Regimens: Partial Pharmacokinetic Parameters
133
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
133
Dosage Regimens: Designs and Approaches
239
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
239


